NORD, FDA & Pfizer will be there- get involved now

Time is running out to get involved at the World Orphan Drug Congress USA! This is your best opportunity for 2018 to showcase your solutions and network with  1000+ attendees from big pharma, biotechs, payers, patient groups, academics and government bodies Download sponsorship prospectus >> Companies already confirmed to attend include:
			EURORDIS  NORD Spark Therapeutics Sangamo Therapeutics Editas Medicine CRISPR Therapeutics  FDA NCATS/NIH CADTH Abeona Therapeutics Orchard Therapeutics McKesson Medicaid Health Plans of America Pfizer Rare Disease Belgium Ministry of Public Health and Social Security Cystic Fibrosis Foundation rareLife solutions Ablynx
					Premier Research Horizon Pharma Japan Agency for Medical Research and Development Invitae bluebird bio Roche Alexion Pharmaceuticals Parexel  Jazz Pharmaceuticals Canadian Organization For Rare Disorders Intellia Therapeutics Inc. Johnson & Johnson Amgen Inc Atlantic Research Group  Cello Health PPD Kids v Cancer Muscular Dystrophy Association
		There are limited opportunities remaining. Contact Andre now at +1 646 619 1797 or andre.singer@terrapinn.comto showcase your solutions to your target audience this April.  Regards,  André Singer General Manager  World Orphan Drug Congress USA 2018 E: andre.singer@terrapinn.com T: +1 646 619 1797